Supplemental Material.Glucagon-like peptide-1 receptor agonists and keratinocyte carcinoma subtype risk: a propensity-matched cohort study in the TriNetX Global Collaborative Network among 943,024 patients with type 2 diabetes
Published: 1 June 2026| Version 1 | DOI: 10.17632/s5h59fb4fw.1
Contributors:
Shangyi Fu, Umer Nadir, Stanislav TolkachjovDescription
Supplemental Material for Research Letter titled "Glucagon-like peptide-1 receptor agonists and keratinocyte carcinoma subtype risk: a propensity-matched cohort study in the TriNetX Global Collaborative Network among 943,024 patients with type 2 diabetes"
Files
Institutions
- Texas Tech UniversityTexas, Lubbock
Categories
Dermatology